Oscar Health Inc (NYSE:OSCR) traded higher on Wednesday afternoon after the company reaffirmed its fiscal year 2025 sales guidance.
OSCR stock has momentum. Stay ahead of the curve here.
What To Know: At the 2025 Wells Fargo Healthcare Conference, Oscar reiterated its expectation for revenue in the range of $12 billion to $12.2 billion, which is above the Wall Street estimate of $11.32 billion.
This news comes on the heels of a strong second quarter, in which revenue rose to $2.86 billion from $2.2 billion in the same period last year, driven by higher membership. The company also recently announced a partnership with grocery chain Hy-Vee to launch a new employer health plan in Des Moines, Iowa.
Despite a second-quarter loss of 89 cents per share, the market has responded positively to the reaffirmed guidance and strategic growth initiatives. Year-to-date, Oscar Health’s stock has gained roughly 28%. The company also projects a 2025 medical loss ratio of 86% to 87%.
Benzinga Edge Rankings: According to Benzinga Edge rankings, Oscar Health shows a strong Value score of 72.16, supported by a positive price trend across short, medium and long-term outlooks.
OSCR Price Action: According to data from Benzinga Pro, Oscar Health shares closed up 7.61% at $17.68 on Wednesday. The stock has a 52-week high of $23.79 and a 52-week low of $11.20.
Read Also: What’s Going On With Salesforce Stock Wednesday?
How To Buy OSCR Stock
Besides going to a brokerage platform to purchase a share — or fractional share — of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.
For Oscar Health, it is in the Financials sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
Image: Shutterstock